🌍 This week, EvaMobs co-coordinator Diana Lousa joined the IPOPI Global Stakeholders' Summit 2026, where patients, researchers and clinicians came together to discuss current challenges and new approaches to antiviral diseases and immunodeficiencies. @ipopi.bsky.social @itqbnova.bsky.social
🎥 Where does EvaMobs stand today, and what's next? Hear from co-coordinators Cláudio M. Soares and Diana Lousa, and meeting host José María Valpuesta, on the outcomes of our recent consortium meeting in Madrid. @itqbnova.bsky.social @cnb-csic.bsky.social www.youtube.com/watch?v=FsX4...
EvaMobs consortium meeting 2026
YouTube video by EvaMobs
youtube.com
How does a drug safely reach patients? 💊 At Career Week in Osijek, EvaMobs researcher Suzana Žunec (IMI) shared the journey from molecule discovery to preclinical safety testing — and IMI’s role in validating antivirals within the EvaMobs platform. ➡️ evamobs.eu/2026/05/08/c...
🌟 EvaMobs joined the 2nd Peptides in Biology & Materials meeting at Sofia University 🇧🇬 The event focused on linking computational peptide research with experimental applications. Diana Lousa presented how peptides can help tackle viral pandemics, from entry mechanisms to therapeutic strategies. ✨
🦠 At the Microbiology Society Annual Conference, EvaMobs researcher Marta Alenquer shared advances in antiviral development against SARS-CoV-2: “We identified four candidates with strong neutralising capacity.” Read more: evamobs.eu/2026/05/05/m... #Microbio26 @microbiologysociety.org
💡 Preparing for future health crises is not only a scientific challenge, but also a societal one. EvaMobs members contributed to the #BioPlaTTAR interactive public session on responsible leadership in future health crises. @itqbnova.bsky.social | @cnb-csic.bsky.social | @caixaresearch.bsky.social.
Three years into #EvaMobs, we met again in Madrid 🇪🇸 From designing to testing thousands of monobodies, nanobodies, and miniproteins, we’re learning what works and narrowing down what could make a real impact.🔍 Next step: move successful candidates to pre-clinical testing!🚀 #PandemicPreparedness
📬 Missed our latest newsletter? Catch up here: mailchi.mp/f55c86f7e468... Including: ✔️ Our progress in protein design, production & validation ✔️ Upcoming events ✔️ Recent publications Stay in the loop - subscribe for updates straight to your inbox: evamobs.eu#newsletter
💡 How can we stay ahead of viruses like RSV? At Bioinformatics Open Days, André Bagão shared work on computationally designed antiviral biologics targeting RSV. Promising candidates show stability, no cytotoxicity, and strong neutralization. ➡️ evamobs.eu/2026/04/07/e... @itqbnova.bsky.social
🎉 Congratulations to Sirine Gaieb on successfully defending her MSc thesis! Her research focused on the computational design of Miniprotein and Monobody binders for Hemagglutinin of influenza H5N1. We thank her for her contributions and wishing her all the best ahead!🌟 @itqbnova.bsky.social
📢 Registrations are now open for the 5th European #RosettaCon – Crossing Boundaries with Protein Design! 📍 Oct 28–30, 2026 | Universidade Nova de Lisboa ⏰ Early bird, abstracts & travel grants close May 31 More info on the website: europeanrosettacon.org
evamobs.bsky.social@evamobs.bsky.social · 5mo agoITQB NOVA (Universidade Nova de Lisboa), EvaMobs’ coordinator, will host European RosettaCon 2026! Theme: “Crossing Boundaries with Protein Design” 📅 28–30 Oct 2026 | 📍 Lisbon Registration & abstracts open in March. Details: europeanrosettacon.org #RosettaCon #ProteinDesign @itqbnova.bsky.social
ITQB NOVA (Universidade Nova de Lisboa), EvaMobs’ coordinator, will host European RosettaCon 2026! Theme: “Crossing Boundaries with Protein Design” 📅 28–30 Oct 2026 | 📍 Lisbon Registration & abstracts open in March. Details: europeanrosettacon.org #RosettaCon #ProteinDesign @itqbnova.bsky.social
📬 Want to receive the latest updates and progress from the EvaMobs project straight to your inbox? Make sure to subscribe to the EvaMobs newsletter and stay in the loop on how we're strengthening the EU's pandemic preparedness. 🦠 ➡️ Subscribe here: https://evamobs.eu/#newsletter
🦠 What if we had a way to fight any virus and respond to an outbreak faster? That’s the challenge EvaMobs aims to solve, by creating a novel platform developing antivirals adapted to a broad range of viruses. 🚀 💡 How will we do this? Watch our project video!👇
🔬 1 year in – where do we stand? 🚀 The #EVAMOBs team has wrapped up 2 days of discussions in Zagreb, marking 1 year of collaboration towards strengthening EU #PandemicPreparedness! 🇪🇺🦠 👉 Read more about the meeting highlights: https://evamobs.eu/2025/04/04/2nd-general-meeting/
EvaMobs 2nd General Meeting: where do we stand one year later? - EvaMobs | Strengthening the EU's pandemic preparedness
On April 2-3, 2024, the EvaMobs team gathered in Zagreb, Croatia, for its second in-person General Meeting, marking a full year of progress in strengthening EU pandemic preparedness!
evamobs.eu
🔍 Join us at the EvaMobs Outbreak Room during European Researchers' Night in Oeiras! 🧩Race to find the best antiviral drugs for a new virus. Every minute counts! 🧪 🗓️ Sept 27, 4-10 PM at Oeiras Marina. ➡️https://t.co/KAYgEWLThH #EuropeanResearchersNight #NEI2024 #NEIOeiras
The DGS in Portugal is offering free seasonal RSV immunization for newborns this fall/winter 2024-2025.💉 At EvaMobs, we’re dedicated to developing targeted biopharmaceuticals to quickly and effectively fight viral threats like RSV. 🧬 https://x.com/saude_pt/status/1823041605848232011
Are we prepared for the next pandemic? EvaMobs researchers Miguel Castanho and Claudio Soares, along with former Portuguese Minister of Education Tiago Brandão Rodrigues, engaged in a discussion on pandemic preparedness, for the Portuguese public. ➡️https://evamobs.eu/2024/05/10/elementor-568/
🎉 The EU-funded EvaMobs project has officially kicked off! 🚀 Over the next 5 years, our international team of experts is set to change antiviral development! Read more about the project and how we plan to strengthen EU’s pandemic preparedness: ➡️https://evamobs.eu/2024/02/06/kick-off/
